Prediction and Secondary Prevention of Fractures (NOFRACTsub)

March 3, 2020 updated by: Frede Frihagen, Oslo University Hospital

Prediction and Secondary Preventing of Fractures in a Norwegian Population. A Substudy of Norwegian Capture the Fracture Initiative

The purpose of this study is to investigate patient related factors that contribute to increased risk of recurrent fractures and to investigate patient adherence to prescribed anti-osteoporotic drugs.

Study Overview

Detailed Description

A standardized treatment program of osteoporosis will be introduced successively at 7 hospitals in Norway from April 2015 to January 2016. This Project is named NoFRACT (Norwegian Capture the Fracture Initiative https://clinicaltrials.gov/show/NCT02536898). Patients above 50 years of age, who recently have suffered a fragility fracture, will be offered examination of osteoporosis and treatment if indicated. Some of these patients will be asked to participate in this consent-based sub-study (NoFRACTsub). At baseline, the patients will be asked to answer a questionnaire, collect blood-sample for to outline possible causes for osteoporosis, in addition to Dual X-Ray Apsopiometry (DXA) scan including bone mineral density(BMD), trabecular bone score(TBS) and vertebral fracture assessment (VFA). At 1-year follow-up there will be a brief questionnaire and measuring of BTM. At 2-year follow-up there will be a brief questionnaire in addition to repeated measurement of DXA including BMD, TBS and VFA. All data will be stored securly at the designated server at the University of Oslo, Service of sensitive data, TSD.

Study Type

Observational

Enrollment (Actual)

840

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Drammen, Norway
        • Drammen Hospital
      • Molde, Norway
        • Molde Hospital
      • Oslo, Norway, 0408
        • Orthopedic Center, Ulleval University Hospital
      • Tromsø, Norway
        • University Hospital of North Norway
    • Gjettum
      • Sandvika, Gjettum, Norway
        • Baerum hospital
    • Trønderlag
      • Trondheim, Trønderlag, Norway
        • St. Olavs Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients already enrolled in NoFRACT main-study. Some patients will be asked to participate in this consent based sub-study, and must be able to answer questionairies, undergo DXA scan and bloodtests at baseline and follow-up.

Description

Inclusion Criteria:

  • Patients participating in NoFRACT
  • Recent low-trauma vertebral or non-vertebral fracture
  • Written patient consent

Exclusion Criteria:

  • Fractures of scull, face, toes or fingers
  • Short life expectancy
  • Patients not competent or willing to give consent
  • Patients having difficulties in answering questionairies, undergoing a DXA scan, and show up on the follow-ups,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients from NoFRACT
Patients from NoFRACT who consent to participate in this sub-study, will be offered examination and treatment with anti-osteoporotic drugs cf. treatment algorithm in the main-study. I.e. if osteoporosis is present clinically or at DXA scan, treatment is started.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fragility fractures
Time Frame: 2 years
Number of new fractures during observation periode
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone mineral Density (BMD)
Time Frame: Baseline, 2 years
BMD in g/cm2 measured by DXA at both hips and lumbar spine. We want to study if there is a correlation between BMD an incidence of new fractures
Baseline, 2 years
Trabecular Bone Score (TBS)
Time Frame: Baseline, 2 years
TBS is an absolute value calculated from the DXA scans of L1-L4. We want to see if TBS can be used as a predictor of future fractures
Baseline, 2 years
Spinal Deformity Index (SDI)
Time Frame: Baseline, 2 years
Grading of vertebral fractures (SQ1=1 point, SQ2 =2 points, SQ3= 3 points) by Vertebral Fracture Assessment of lateral DXA scans. The total of points is the SDI. We want to see if there is a correlation between present fractures at baseline and future fractures
Baseline, 2 years
s-CTX
Time Frame: At 1 year follow-up
Fasting CTX (carboxy-terminal collagen crosslinks)in serum, measured in pg/ml
At 1 year follow-up
s-PINP
Time Frame: At 1 year follow-up
Fasting PINP (Procollagen I Intact N-Terminal)in Serum, measured in mcg/L
At 1 year follow-up
FRAX score
Time Frame: Baseline
Calculation 10-year fracture risk for major osteoporotic and hip fractures by FRAX calculated during DXA scanning, on a population treated with AOD
Baseline
Garvan score
Time Frame: Baseline
Calculation of 10-year fracture risk for major osteoporotic and hip fracture using online available Garvan Nomogram, on a population treated with AOD.
Baseline
Self-reported adherence to anti-osteoporotic drugs (AOD)
Time Frame: Baseline, 1 year, 2 years
Self-reported use of AOD by questionnaire. Answer yes or no. If terminating of the treatment, patients will be asked to describe why.
Baseline, 1 year, 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2015

Primary Completion (Actual)

December 31, 2017

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

November 17, 2015

First Submitted That Met QC Criteria

November 17, 2015

First Posted (Estimate)

November 20, 2015

Study Record Updates

Last Update Posted (Actual)

March 4, 2020

Last Update Submitted That Met QC Criteria

March 3, 2020

Last Verified

March 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Subscribe